Melatonin combination therapy for improving sleep quality

作者: Timothy J. Barberich

DOI:

关键词: Sleep qualityPharmacologyEszopicloneCombination therapyInsomniaMedicineMelatoninSedative agent

摘要: One aspect of the present invention relates to pharmaceutical compositions comprising a sedative agent; and melatonin or analog, collectively referred as 'melatonin agents.' In preferred embodiment, agent is eszopiclone. The are useful in treatment various sleep disorders. addition, also method treating patient suffering from abnormality insomnia administering therapeutically effective amount composition invention.

参考文章(26)
Patricia Schlagenhauf, Robert Steffen, Alois Tschopp, Andrea Suhner, Richard Johnson, Ilse Höfer, Effectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lag. Aviation, Space, and Environmental Medicine. ,vol. 72, pp. 638- 646 ,(2001)
Bojidar Stankov, Gabriele Biella, Franco Fraschini, Luigi F. Strambi, Pharmaceutical compositions active in the therapy of sleep disorders ,(1993)
Masaomi Miyamoto, Shigenori Ohkawa, Method for treating or preventing sleep disorders ,(1999)
Chrisantha H. Senanayake, Paul D. Rubin, Roger A. Bakale, Thomas P. Jerussi, Tingjian Xiang, Yaping Hong, Fran A. Mcconville, Methods of making and using n-desmethylzopiclone Official Gazette of the United States Patent and Trademark Office Patents. ,(2000)
Claude Cotrel, Gerard Roussel, Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing same Official Gazette of the United States Patent and Trademark Office Patents. ,(1992)